164 related articles for article (PubMed ID: 36916438)
1. The antinociceptive activity and mechanism of action of cannabigerol.
Wen Y; Wang Z; Zhang R; Zhu Y; Lin G; Li R; Zhang J
Biomed Pharmacother; 2023 Feb; 158():114163. PubMed ID: 36916438
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis.
Rodriguez CEB; Ouyang L; Kandasamy R
Behav Pharmacol; 2022 Apr; 33(2&3):130-157. PubMed ID: 33709984
[TBL] [Abstract][Full Text] [Related]
4. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.
Robaina Cabrera CL; Keir-Rudman S; Horniman N; Clarkson N; Page C
Pulm Pharmacol Ther; 2021 Aug; 69():102047. PubMed ID: 34082108
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.
Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807
[TBL] [Abstract][Full Text] [Related]
6. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
[TBL] [Abstract][Full Text] [Related]
7. Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model.
Eeswara A; Pacheco-Spiewak A; Jergova S; Sagen J
PLoS One; 2023; 18(3):e0282920. PubMed ID: 36913400
[TBL] [Abstract][Full Text] [Related]
8. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
Lötsch J; Weyer-Menkhoff I; Tegeder I
Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
[TBL] [Abstract][Full Text] [Related]
9. Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews.
Rock EM; Goodwin JM; Limebeer CL; Breuer A; Pertwee RG; Mechoulam R; Parker LA
Psychopharmacology (Berl); 2011 Jun; 215(3):505-12. PubMed ID: 21243485
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol and Cannabigerol, Nonpsychotropic Cannabinoids, as Analgesics that Effectively Manage Bone Fracture Pain and Promote Healing in Mice.
Khajuria DK; Karuppagounder V; Nowak I; Sepulveda DE; Lewis GS; Norbury CC; Raup-Konsavage WM; Vrana KE; Kamal F; Elbarbary RA
J Bone Miner Res; 2023 Nov; 38(11):1560-1576. PubMed ID: 37597163
[TBL] [Abstract][Full Text] [Related]
11. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.
De Petrocellis L; Vellani V; Schiano-Moriello A; Marini P; Magherini PC; Orlando P; Di Marzo V
J Pharmacol Exp Ther; 2008 Jun; 325(3):1007-15. PubMed ID: 18354058
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.
Fischedick J; Van Der Kooy F; Verpoorte R
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):201-7. PubMed ID: 20118579
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids in clinical practice.
Williamson EM; Evans FJ
Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
El-Alfy AT; Ivey K; Robinson K; Ahmed S; Radwan M; Slade D; Khan I; ElSohly M; Ross S
Pharmacol Biochem Behav; 2010 Jun; 95(4):434-42. PubMed ID: 20332000
[TBL] [Abstract][Full Text] [Related]
15. Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol.
Pagano E; Montanaro V; Di Girolamo A; Pistone A; Altieri V; Zjawiony JK; Izzo AA; Capasso R
Nat Prod Commun; 2015 Jun; 10(6):1009-12. PubMed ID: 26197538
[TBL] [Abstract][Full Text] [Related]
16. Selective Extraction of Cannabinoid Compounds from Cannabis Seed Using Pressurized Hot Water Extraction.
Nuapia Y; Tutu H; Chimuka L; Cukrowska E
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183432
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways.
Viereckl MJ; Krutsinger K; Apawu A; Gu J; Cardona B; Barratt D; Han Y
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740979
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Analgesic Effect of High-Cannabidiol-Content Cannabis Extracts in Different Pain Models by Using Polymeric Micelles as Vehicles.
Román-Vargas Y; Porras-Arguello JD; Blandón-Naranjo L; Pérez-Pérez LD; Benjumea DM
Molecules; 2023 May; 28(11):. PubMed ID: 37298776
[TBL] [Abstract][Full Text] [Related]
19. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms.
Russo EB; Cuttler C; Cooper ZD; Stueber A; Whiteley VL; Sexton M
Cannabis Cannabinoid Res; 2022 Oct; 7(5):706-716. PubMed ID: 34569849
[No Abstract] [Full Text] [Related]
20. The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice.
Zhou C; Assareh N; Arnold JC
Cannabis Cannabinoid Res; 2022 Jun; 7(3):294-303. PubMed ID: 34182770
[No Abstract] [Full Text] [Related]
[Next] [New Search]